Breast Cancer Trial, Recruiting NCT05305092 Sponsor: Tang-Du Hospital Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT05305092
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People diagnosed with primary stage I or stage II breast cancer.
  • Women who have not yet gone through menopause, as determined using standard breast cancer guidelines.
  • People who have not yet started any cancer treatment other than surgery (if chemotherapy before surgery is needed, enrollment must happen before that chemotherapy begins).
  • People with a general health and activity level rated at 0 or 1 on a standard medical performance scale, meaning largely able to carry out normal daily activities (confirm with trial site).
  • People who are able to understand and fill out various questionnaires or rating scales.
  • People who are right-handed.
  • Women who could potentially become pregnant must be willing to use a medically approved highly effective form of contraception (such as an intrauterine device, contraceptive pill, or condom) throughout the study.
  • People who are willing to sign a consent form and take part in the study voluntarily.

Who may not be able to join:

  • People with a nervous system disease, a history of losing consciousness for long periods, a head injury, or any condition that affects thinking or memory.
  • People with a current or past history of epilepsy, dementia, or a learning disability.
  • People with a past history of mental health or psychiatric conditions.
  • People with a previous diagnosis of cancer (other than the current breast cancer).
  • People for whom an MRI scan would be unsafe or unsuitable, including those with a pacemaker, defibrillator, hearing implant, insulin pump, medication delivery device, or other metal implants in the body, as well as those with severe fever or a fear of enclosed spaces.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Menghui Yuan, phd, Tang-Du Hospital

Phone: 0086-13519196610

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Tang-Du Hospital
Registry
ClinicalTrials.gov
Start date
31 May 2022
Est. completion
30 May 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Change of gray matter volume of whole brain; Change of white matter integrity of whole brain.; Change of metabolism of glucose in the brain; Change of functional connectivity of whole brain; Change of verbal learning and memory; Change of information processing speed; Change of executive function; Change of attention, verbal short term and working memory; Change of life quality.; Change of anxiety; Change of depression; Change of fatigue; Change of sleep

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov